Copyright & Licensing

The International Journal of NeuroOncology and Therapeutics is dedicated to ensuring that all works published in our journal are freely accessible and properly attributed. This section outlines our copyright and licensing policies for authors, readers, editors, abstracting databases, and libraries and repositories.

For Authors

  1. Copyright Ownership
  • As an author, you retain full copyright of your work. This means you maintain ownership and control over your intellectual property.
  1. Publishing Rights
  • By submitting your manuscript to the International Journal of NeuroOncology and Therapeutics, you grant the journal the right to be the first publisher of your work. This right is established once your manuscript is accepted for publication.
  1. Creative Commons License
  • All articles published by the International Journal of NeuroOncology and Therapeutics are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
  • This license allows others to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, including commercial uses, provided that proper attribution is given to the original author(s) and source.
  1. Attribution Requirements
  • Proper attribution must include the author’s name, the title of the work, a link to the CC BY 4.0 license, and an indication of any changes made to the original work.
  • The attribution must not imply endorsement by the authors or the International Journal of NeuroOncology and Therapeutics.
  1. Non-Exclusive Distribution
  • Authors may enter into additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., posting the article in institutional repositories or publishing it in a book), with an acknowledgment of its initial publication in the International Journal of NeuroOncology and Therapeutics.
  1. Responsibility for Permissions

Authors must obtain permission to use any third-party material included in their manuscript. This includes images, figures, tables, or text excerpts. Proof of permission must be provided upon submission.

For Readers

  1. Access and Use
  • All articles published in the International Journal of NeuroOncology and Therapeutics are freely accessible to the public immediately upon publication.
  • Under the CC BY 4.0 license, readers are permitted to share and adapt the articles, provided that proper attribution is given to the original author(s) and source.
  1. Attribution Requirements
  • When using or sharing content from the International Journal of NeuroOncology and Therapeutics, you must give appropriate credit, provide a link to the license, and indicate if any changes were made.
  • You may not use the material in a way that suggests endorsement by the authors or the journal without explicit permission.

For Editors

  1. Editorial Independence
  • Editors at the International Journal of NeuroOncology and Therapeutics are committed to maintaining the highest standards of editorial independence and integrity.
  • Editorial decisions are based on the quality and relevance of the manuscript and are not influenced by external pressures or commercial interests.
  1. Managing Copyright and Licensing
  • Editors ensure that all published content adheres to the journal’s copyright and licensing policies.
  • They verify that authors have obtained the necessary permissions for any third-party materials included in their manuscripts.
  1. Attribution and Acknowledgment
  • Editors are responsible for ensuring that proper attribution is given to authors and contributors.
  • They oversee the acknowledgment of funding sources, conflicts of interest, and any other relevant disclosures.

For Abstracting Databases

  1. Metadata and Indexing
  • The International Journal of NeuroOncology and Therapeutics provides comprehensive metadata for all published articles to facilitate accurate indexing in abstracting databases.
  • Metadata includes author names, titles, abstracts, keywords, and other relevant information to enhance discoverability.
  1. Access and Attribution
  • Abstracting databases are encouraged to index articles from the International Journal of NeuroOncology and Therapeutics under the CC BY 4.0 license.
  • Proper attribution must be given to the original authors and the journal when displaying abstracts or excerpts.
  1. Licensing Information
  • Databases should display licensing information clearly, indicating that articles are licensed under the CC BY 4.0 license.

For Libraries and Repositories

  1. Institutional Repositories
  • Libraries and institutional repositories are encouraged to include articles from the International Journal of NeuroOncology and Therapeutics in their collections.
  • Articles can be freely shared and adapted under the CC BY 4.0 license, with proper attribution to the original authors and the journal.
  1. Digital Preservation
  • The International Journal of NeuroOncology and Therapeutics participates in digital preservation initiatives such as LOCKSS and CLOCKSS to ensure the long-term availability of its content.
  • Libraries can rely on these preservation networks for the durability and reliability of archived content.
  1. Cataloging and Metadata
  • Libraries are provided with detailed metadata for all published articles to ensure proper cataloging and discoverability within their systems.
  • Metadata includes essential information such as author names, article titles, publication dates, abstracts, and keywords.

Contact Information

For any questions regarding this copyright and licensing notice, or if you need further assistance, please contact us at editor@ijnot.com